Mingde Biotechnology Plans to Repurchase Company Shares for 100 Million to 200 Million Yuan

NightAirdropper · 2026-03-24T02:24:51+00:00

Mingde Biology announced that it will repurchase shares through centralized competitive bidding, with a total amount between 100 million and 200 million yuan, aiming to boost investor confidence and safeguard shareholder rights. On that day, the stock hit the daily limit-down, drawing market attention.

NightAirdropper

2026-03-24 02:24:51

Abstract generation in progress

Beijing Business Daily (Reporter Ding Ning) March 23 — Mingde Bio (002932) announced on the evening of March 23 that the company will repurchase its shares through centralized bidding, with a total repurchase amount not exceeding 200 million yuan and not less than 100 million yuan.

Mingde Bio stated that the purpose of the share repurchase is based on confidence in the company’s future development prospects and a high recognition of the company’s value. To protect the interests of investors and boost investor confidence, the repurchased shares will be used to maintain the company’s value and shareholders’ rights and interests.

It is worth noting that on March 23, Mingde Bio hit the daily limit-down of “one” character all day.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.